الفهرس | Only 14 pages are availabe for public view |
Abstract Endoscopic ultrasound (EUS) was developed in the 19808. Its main use at that time was in the staging of gastrointestinal tumors. Initially used as a diagnostic tool, since the early 1990s it has been increasingly utilized in intervention and therapy. Its uses have broadened such that it now has indications for extraintestinal pathology. Use of EUS will continue to grow as new technology, such as the thin miniprobe, dual-plane reconstruction (DPR), intraductal probes, and the new electronic radial echoendoscope, become available. Over the next few years, EUS is foreseen as becoming one of the most powerful gastroenterological, radiological, and therapeutic instruments, catalyzing significant changes in patient management. Endoscopic ultrasound is performed using either an ultrasound probe, which is passed through the channel of a standard endoscope, or with an echoendoscope with an ultrasound transducer built into its tip. Because of its closer, internal vantage point, EUS can deliver enhanced imaging resolution compared to conventional ultrasound, which is conducted transcutaneously. In addition, an echoendoscope can maneuver in unique imaging planes and remove intraluminal air, which often obscures imaging during conventional ultrasound. There are two main EUS imaging modalities, including curvilinear and radial. Curvilinear array (CLA) instruments create ultrasound images parallel to the axis of the insertion tube. This orientation facilitates real-time ultrasonographic guidance of interventions such as fme needle . aspiration (FNA), allowing the physician to view simultaneously the needle and the target area of interest on the video monitor. Real-time viewing allows the |